Accredited Wealth Management LLC Takes Position in Synopsys, Inc. $SNPS

Accredited Wealth Management LLC purchased a new position in shares of Synopsys, Inc. (NASDAQ:SNPS) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 122 shares of the semiconductor company’s stock, valued at approximately $52,000.

A number of other institutional investors also recently added to or reduced their stakes in the business. GAMMA Investing LLC increased its position in Synopsys by 54,286.0% during the 1st quarter. GAMMA Investing LLC now owns 1,196,492 shares of the semiconductor company’s stock worth $513,116,000 after purchasing an additional 1,194,292 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in shares of Synopsys by 21.5% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 5,902,696 shares of the semiconductor company’s stock valued at $2,864,933,000 after buying an additional 1,045,326 shares in the last quarter. Nuveen LLC acquired a new position in Synopsys during the first quarter worth $341,480,000. Pictet Asset Management Holding SA grew its holdings in Synopsys by 38.3% during the first quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company’s stock worth $1,043,518,000 after acquiring an additional 673,837 shares during the period. Finally, Ameriprise Financial Inc. raised its position in Synopsys by 26.2% in the fourth quarter. Ameriprise Financial Inc. now owns 1,888,181 shares of the semiconductor company’s stock worth $916,441,000 after acquiring an additional 391,681 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Insider Transactions at Synopsys

In related news, CFO Shelagh Glaser sold 7,310 shares of the firm’s stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $485.72, for a total transaction of $3,550,613.20. Following the sale, the chief financial officer owned 15,291 shares in the company, valued at approximately $7,427,144.52. This trade represents a 32.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CRO Richard S. Mahoney sold 9,010 shares of Synopsys stock in a transaction that occurred on Wednesday, June 18th. The stock was sold at an average price of $471.21, for a total transaction of $4,245,602.10. Following the completion of the sale, the executive directly owned 1,485 shares of the company’s stock, valued at $699,746.85. The trade was a 85.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 27,686 shares of company stock worth $13,001,048 over the last ninety days. 0.62% of the stock is currently owned by corporate insiders.

Synopsys Stock Performance

NASDAQ SNPS opened at $601.13 on Thursday. The company has a quick ratio of 6.85, a current ratio of 7.02 and a debt-to-equity ratio of 1.01. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The business has a fifty day moving average of $565.67 and a 200-day moving average of $499.85. The stock has a market cap of $93.27 billion, a price-to-earnings ratio of 43.40, a price-to-earnings-growth ratio of 4.06 and a beta of 1.15.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings data on Wednesday, May 28th. The semiconductor company reported $3.67 EPS for the quarter, beating analysts’ consensus estimates of $3.40 by $0.27. Synopsys had a return on equity of 17.09% and a net margin of 34.77%.The business had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.60 billion. During the same quarter last year, the company earned $3.00 earnings per share. The business’s revenue for the quarter was up 10.3% compared to the same quarter last year. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS. Q3 2025 guidance at 3.820-3.87 EPS. As a group, analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Rosenblatt Securities boosted their target price on shares of Synopsys from $625.00 to $650.00 and gave the stock a “buy” rating in a research report on Friday, July 25th. KeyCorp upped their target price on Synopsys from $540.00 to $610.00 and gave the company an “overweight” rating in a report on Thursday, July 10th. Piper Sandler raised their price target on Synopsys from $615.00 to $660.00 and gave the company an “overweight” rating in a research report on Monday, July 21st. Needham & Company LLC reiterated a “buy” rating and issued a $660.00 price objective (up from $650.00) on shares of Synopsys in a research report on Tuesday, July 15th. Finally, Bank of America increased their price objective on shares of Synopsys from $575.00 to $625.00 and gave the company a “buy” rating in a research note on Wednesday, July 16th. Thirteen research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $630.67.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.